GB Patent

GB2321190A — Medicament pack for treating Parkinson's Disease

Assigned to Britannia Pharmaceuticals Ltd · Expires 1998-07-22 · 28y expired

What this patent protects

A medicament treating Parkinson's disease which is in the form of a pack comprising a dosage of N-propyl norapomorphine (NPA) physiologically acceptable salts or prodrugs thereof and a dosage of a catechol-O-methyl-transferase (COMT) inhibitor.

USPTO Abstract

A medicament treating Parkinson's disease which is in the form of a pack comprising a dosage of N-propyl norapomorphine (NPA) physiologically acceptable salts or prodrugs thereof and a dosage of a catechol-O-methyl-transferase (COMT) inhibitor.

Drugs covered by this patent

Patent Metadata

Patent number
GB2321190A
Jurisdiction
GB
Classification
—
Expires
1998-07-22
Drug substance claim
No
Drug product claim
No
Assignee
Britannia Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.